Article Details
Retrieved on: 2021-12-08 05:36:49
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Sotrovimab is an investigational SARS-CoV-2 neutralising monoclonal antibody. Shares of Vir Biotechnology Inc., the drug's co-developer, were up as ...
Article found on: www.detroitnews.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here